Saxena Parag's most recent trade in Reviva Pharmaceuticals Holdings Inc. was a trade of 8,200 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 10, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reviva Pharmaceuticals Hol... | Saxena Parag | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 8,200 | 8,200 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Parag Saxena | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 3,900 | 3,900 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Parag Saxena | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 5,300 | 5,300 | - | - | Stock Option (right to buy) | |
| Reviva Pharmaceuticals Hol... | Parag Saxena | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 4,000 | 4,000 | - | - | Stock Option (right to buy) |